SURG (SurgePays, Inc. Common Stock) Stock Analysis - Financials

SurgePays, Inc. Common Stock (SURG) is a publicly traded Technology sector company. As of May 21, 2026, SURG trades at $0.50 with a market cap of $13.28M and a P/E ratio of -0.28. SURG moved -5.29% today. Year to date, SURG is -70.58%; over the trailing twelve months it is -84.27%. Its 52-week range spans $0.46 to $3.47. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces SURG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SURG's key financials?

SURG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SURG recently traded at $0.50. Market cap is $13.28M. P/E ratio is -0.28. Revenue is $56.96M.

SURG Key Metrics

Key financial metrics for SURG
MetricValue
Price$0.50
Market Cap$13.28M
P/E Ratio-0.28
EPS$-1.80
Dividend Yield0.00%
52-Week High$3.47
52-Week Low$0.46
Volume0
Avg Volume0
Revenue (TTM)$56.96M
Net Income$-36.07M
Gross Margin-18.59%

SURG Annual Financials

YearRevenueNet IncomeEPS
2025$56.96M$-36.07M$-1.80
2024$60.88M$-45.94M$-2.39
2023$137.14M$20.64M$1.45
2022$121.54M$-553.23K$-0.05

Latest SURG News

Recent SURG Insider Trades

  • May David Allen bought 28.42K (~$45.45K) on Dec 10, 2025.
  • May David Allen bought 10.00K (~$16.20K) on Dec 10, 2025.
  • May David Allen sold 63.00K (~$177.28K) on Jun 6, 2025.

SURG Analyst Consensus

2 analysts cover SURG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.

Common questions about SURG

What are SURG's key financials?
SURG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SURG recently traded at $0.50. Market cap is $13.28M. P/E ratio is -0.28. Revenue is $56.96M.
Is SURG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.
SURG

SURG